Video Library

Stem cell transplants in older patients have, historically, had lower success rates than those in younger patients. This presentation describes several new promising strategies to improve transplant outcomes and survival rates in older patients. Many thanks to Pharmacyclics, an AbbVie Company, and Janssen Biotech, Inc., Jazz Pharmaceuticals and Omeros Corporation, whose support, in part helped make this workshop possible.

Ovarian failure, estrogen deficiency, decreased sex drive, infertility and vaginal graft-versus-host disease are a concern for many women after a stem cell transplant. This presentation discusses what causes these problems and treatment options, particularly for women with vaginal graft-versus-host disease (GVHD).

The way we think and process information can change after transplant, at least in the short-term time. Called cognitive problems, paying attention, concentrating, remembering things and learning new skills can be difficult. This presentation discusses the factors that can cause cognitive problems and strategies to manage them.

Insomnia, which is defined as difficulty falling or staying asleep, is three times higher among transplant recipients than the general population. Cognitive behavioral therapy for insomnia (CBT-I) is a safer a treatment than sleep medications and more effective long-term.

The skin is the most common target of graft-versus-host disease (GVHD), a frequent complication that occurs after a transplant using donor cells. Although most skin changes after transplant are mild or moderate, more severe skin problems are possible.

Approximately 60% of patients with chronic graft-versus-host disease (GVHD) have GVHD in their mouth. Patients, as well as dentists, often confuse oral GVHD with other mouth problems. Seeking treatment from a dentist familiar with chronic GVHD is important. Many thanks to Kadmon, a Sanofi Company. whose support, in part, made this presentation possible.

Medical marijuana offers new options for managing problems arising from cancer treatment. This presentation reviews the potential benefits and risks of cannabis, who is most likely to benefit, and who should avoid using cannabis.

Bone loss is common after transplant and can lead to fractures with severe consequences for transplant recipients. This presentation describes the causes of bone loss and the diagnostic procedures and treatments that can minimize damage and maintain patient quality of life.

Children who receive bone marrow or stem cell transplant may experience cognitive challenge after treatment. This presentation identifies these challenges, describes how they can be assessed, and suggests school and home-based remedies for these issues.

Presenters: Richard Champlin MD, The University of Texas MD Anderson Cancer Center Luke Mountjoy DO, Colorado Blood Cancer Institute, part of the Sarah Cannon Cancer Institute at Presbyterian/St. Luke’s Medical Center Luis Pineiro MD, Baylor, Scott & White/Texas Oncology BMT Program -Dallas

Transplant recipients have unique and varied nutritional requirements during the first 100 days after transplant, so a consultation with a registered dietitian is important. Maintaining a healthy diet long-term can help avoid medical problems. This presentation explains which foods need to be included in a healthy diet, how to navigate a grocery store to get truly nutritious foods and addresses various marketing gimmicks and claims about “fad” diets.

Transplant recipients have an elevated risk of skin problems after transplant that require ongoing surveillance, early detection, and prompt treatment. This presentation describes some of the potential skin problems after transplant, and how to maintain good skin health long-term.